Trial intelligence / Profile preview

HP-5000 in Subjects With Osteoarthritis of the Knee

NCT03277066Phase 2Completed

Sponsor
Noven Pharmaceuticals
Start
Sep 2017
Primary completion
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of diclofenac in knee osteoarthritis (OA), sponsored by Noven Pharmaceuticals. Started Sep 2017; status: completed.

02

Drugs

diclofenac
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT03277066.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03277066.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call